Showing results (261-270 of 297) with videos related to

Sort By:
Pageof 30
Journal of Drugs in Dermatology : JDD|September 16, 2017
Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled StudyLinda Stein Gold, Kim Papp, Charles Lynde, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 7, 2025
Underutilized treatments for patients with refractory cancer pain: a qualitative study assessing the use of intrathecal drug delivery devices in the United Kingdom compared to alternative treatments in cancer pain managementVictoria Barnosky, Matthew Brown, Somnath Bagchi, et al.
Orphanet Journal of Rare Diseases|April 13, 2017
Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delaysYvonne Zurynski, Marie Deverell, Troy Dalkeith, et al.
Scientific Reports|April 12, 2017
Zero-tolerance biosecurity protects high-conservation-value island nature reserveJohn K Scott, Simon J McKirdy, Johann van der Merwe, et al.
Annals of Plastic Surgery|January 26, 2010
Expression of receptor for activated C kinase 1 in healing skin and mucosal woundsLatha Satish, Justin Hogg, Sandra Johnson, et al.
Plos One|May 6, 2010
Chaperonin containing T-complex polypeptide subunit eta (CCT-eta) is a specific regulator of fibroblast motility and contractilityLatha Satish, Sandra Johnson, James H-C Wang, et al.
BMC Research Notes|October 15, 2010
Multiple displacement amplification as an adjunct to PCR-based detection of Staphylococcus aureus in synovial fluidSandeep Kathju, Roger S Lasken, Latha Satish, et al.
Clinical Microbiology Reviews|November 15, 2023
Viral infections and pathogenesis of glaucoma: a comprehensive reviewFaraz Ahmad, Nikhil Deshmukh, Aaron Webel, et al.
Cell Stress & Chaperones|January 8, 2013
Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contractureLatha Satish, David B O'Gorman, Sandra Johnson, et al.
Infection Control and Hospital Epidemiology|September 21, 2011
Prevalence of and risks for internal contamination among hospital staff caring for a patient contaminated with a fatal dose of polonium-210Olivier le Polain de Waroux, Sandra Cohuet, Louise Bishop, et al.
Pageof 30